EcN-Sj16-Exo ameliorates experimental asthma by inhibiting eosinophil extracellular traps formation via N-WASP upregulation
European Respiratory Journal · 2026
DOI: 10.1183/13993003.00948-2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, 2026. Verfasst von Xi Sun und 16 weiteren Autor:innen. Beteiligte Einrichtung: KingMed School of Laboratory Medicine, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Asthma, Extracellular Traps, Wiskott-Aldrich Syndrome Protein, Neuronal, Exosomes. Gefördert von: National Natural Science Foundation of China, Youth Innovation Talent Project of Ordinary university in Guangdong Province, Guangzhou National Laboratory of China.
Abstract (Originalsprache)
Background
Eosinophilic inflammation is a feature of allergic asthma, with eosinophil depletion shown to alleviate symptoms. Elevated levels of eosinophil extracellular traps (EETs) in bronchoalveolar lavage fluid (BALF) correlate with asthma severity. Sj16 is a protein from Schistosoma japonicum with known immunoregulatory properties. Exosomes, with their protective phospholipid bilayer, serve as efficient drug carriers.
Methods
We extracted exosomes secreted by Escherichia coli Nissle 1917 engineered to express Sj16 (EcN-Sj16-Exo), and sought to investigate the role of EcN-Sj16-Exo on asthma. In ovalbumin (OVA)-induced experimental asthma model in mice, EET levels were elevated. The experimental asthma model was treated with EcN-Sj16-Exo. EET formation was assessed using immunofluorescence and scanning electron microscopy. Lung function, airway remodeling, and inflammatory were evaluated. Wiskott-Aldrich syndrome-like ( WASL ) knockout mice and recombinant adeno-associated virus (rAAV)-expressing Neural Wiskott-Aldrich syndrome protein (N-WASP) were used to investigate the potential mechanisms of EcN-Sj16-Exo.
Results
EET formation was increased in sputum and BALF from asthma patients. We demonstrate that Sj16 inhibits EET formation in vitro and localizes primarily in exosomes when secreted by EcN-Sj16. In the experimental asthma model, EcN-Sj16-Exo significantly reduced EET formation. Moreover, EcN-Sj16-Exo significantly attenuated airway hyperreactivity (AHR) and airway remodeling, as evidenced by reduced lung resistance (R L ), improved dynamic compliance (C dyn ), and diminished inflammatory cell infiltration, fibrosis, and mucus hypersecretion. Furthermore, EcN-Sj16-Exo decreased eosinophil and neutrophil counts, IgE, and type 2 cytokines levels in BALF while increasing Treg cells in the spleen. Mechanistically, EcN-Sj16-Exo inhibited EET formation by upregulating N-WASP. WASL knockout mice and AAV6-WASL-mediated N-WASP expression confirmed that EcN-Sj16-Exo alleviates experimental asthma by upregulating N-WASP to inhibit EET formation.
Conclusion
Our findings suggest that EcN-Sj16-Exo represents a promising therapeutic approach in asthma, highlighting the potential of targeting EETs and N-WASP in asthma therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- KingMed School of Laboratory Medicine, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou, China.
- Department of Parasitology of Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
- These authors contributed equally to this work.
- Medical Department, Xizang Minzu University, Xianyang, China.
- KingMed School of Laboratory Medicine, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou, China wanglf@gzhmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Youth Innovation Talent Project of Ordinary university in Guangdong Province
- Guangzhou National Laboratory of China
- Department of Education of Guangdong Province
- Guangdong Provincial Medical Science and Technology Research Foundation
- National Key Research and Development Program of China
- Guangzhou Medical University
- Science and Technology Plan Project of Guangzhou
Zitieren
APA
Sun, X., Liao, Y., Wu, J., Liu, Y., Li, D., Zhu, Z., Huang, Y., Wu, J., Peng, P., Su, J., He, Y., Yanglan, M., Deng, H., Cao, F., Xu, J., Wu, Z., & Wang, L. (2026). EcN-Sj16-Exo ameliorates experimental asthma by inhibiting eosinophil extracellular traps formation via N-WASP upregulation. European Respiratory Journal. https://doi.org/10.1183/13993003.00948-2025
Vancouver
Sun X, Liao Y, Wu J, Liu Y, Li D, Zhu Z, et al. EcN-Sj16-Exo ameliorates experimental asthma by inhibiting eosinophil extracellular traps formation via N-WASP upregulation. European Respiratory Journal. 2026. doi:10.1183/13993003.00948-2025
BibTeX
@article{Sun2026,
author = {Sun, Xi and Liao, Yao and Wu, Ji and Liu, Yuheng and Li, Dinghao and Zhu, Zifeng and Huang, Yun and Wu, Junwei and Peng, Peiying and Su, Jin and He, Yingxin and Yanglan, Mengxi and Deng, Haiyi and Cao, Feiyang and Xu, Junhao and Wu, Zhongdao and Wang, Lifu},
title = {EcN-Sj16-Exo ameliorates experimental asthma by inhibiting eosinophil extracellular traps formation via N-WASP upregulation},
journal = {European Respiratory Journal},
year = {2026},
doi = {10.1183/13993003.00948-2025}
}
EUVIMED